临床病原体的超灵敏检测通过一个目标无放大附带分裂增强CRISPR-CasΦ工具
Huiyou Chen1,2,3, Fengge Song1,2,3, Buhua Wang1,3
1State key laboratory of digital medical engineering, Hainan University, Haikou, 570228, China.
Nature communications
|April 25, 2025
概括
这项研究引入了一种新的CRISPR-CasΦ诊断方法,用于超敏感病原体检测. 该技术显著提高了对qPCR的敏感性,使得血清样本中的细菌能够快速识别.
科学领域:
- 分子生物学分子生物学
- 生物技术是生物技术.
- 诊断 诊断 诊断 诊断
背景情况:
- 目前的临床病原体诊断方法,如qPCR和血液培养,在灵敏度和速度上都有局限性.
- 需要快速,超敏感的方法来检测致病性点.
研究的目的:
- 开发和验证一种基于CRISPR-CasΦ的新方法,用于超敏感病原体检测.
- 通过附带分离机制来增强信号放大,以提高诊断灵敏度.
主要方法:
- 利用双茎循环DNA放大器和CRISPR-CasΦ系统进行目标检测.
- 使用链接器的附带酶分离来释放光信号.
- 实施一个无目标放大,增强抵押分隔的CRISPR-CasΦ (TCC) 方法.
主要成果:
- 实现了超敏感的目标检测,其极限为0.11副本/μL.
- 与定量PCR (qPCR) 相比,表现出更高的灵敏度.
- 在40分钟内在血清中成功检测到低至1.2CFU/mL的致病细菌.
结论:
- TCC方法为临床病原体诊断提供了一种高度敏感和快速的方法.
- 这种基于CRISPR-CasΦ的策略克服了现有诊断技术的局限性.
- 开发的方法对及时准确识别细菌感染有很大的前景.
更多相关视频
10:16Author Spotlight: Development of Simplified CRISPR-Based Tests for Rapid Detection of Infectious Diseases
Published on: August 16, 2024
962
07:59Rapid and Specific Detection of Acinetobacter baumannii Infections Using a Recombinase Polymerase Amplification/Cas12a-based System
Published on: April 25, 2025
51
相关概念视频
CRISPR and crRNAs
16.3K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
16.3K
CRISPR
48.5K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
48.5K
